Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» immuno-oncology
immuno-oncology
BioNTech raises $325M series B round to advance cancer pipeline
Fierce Biotech
Tue, 07/9/19 - 08:39 am
BioNTech
immuno-oncology
RAPT Therapeutics Files For $86 Million IPO
CP Wire
Mon, 07/8/19 - 10:30 am
APT Therapeutics
immuno-oncology
IPOs
RAPT Therapeutics Files For $86 Million IPO
Mon, 07/8/19 - 10:27 am
RAPT Therapeutics
immuno-oncology
IPOs
Sanofi to ax 466 jobs, step up focus on cancer, gene therapy R&D
Fierce Biotech
Thu, 06/20/19 - 09:56 am
Sanofi
layoffs
Germany
France
R&D
immuno-oncology
gene therapy
BIO Roundup: Agenus, FDA, Merck’s Frazier and Much More
BioSpace
Sun, 06/9/19 - 01:49 pm
Agenus
Jamie Dimon
BIO 2019
RWE
FDA
immuno-oncology
Merck
Ken Frazier
UK
Personalis Updates $122 Million IPO Filing
CP Wire
Fri, 06/7/19 - 12:05 pm
Perosnalis
IPOs
immuno-oncology
5 novel immuno-oncology targets to know before ASCO
Biopharma Dive
Thu, 05/23/19 - 10:54 pm
immuno-oncology
ASCO 2019
STING
LAG-3
TIM-3
TGF-Beta
OX40
6 Things Johnson & Johnson Wants You to Know About Its Pharmaceuticals
Motley Fool
Sat, 05/18/19 - 08:42 pm
JNJ
devices
Remicade
consumer health
immuno-oncology
Triumvira Submits IND Application to the FDA and CTA to Health Canada to Evaluate Immuno-Oncology Candidate
CP Wire
Wed, 05/1/19 - 10:29 am
Triumvira
TAC01-CD19
immuno-oncology
FDA
Health Canada
Triumvira Submits IND Application to the FDA and CTA to Health Canada to Evaluate Immuno-Oncology Candidate
Wed, 05/1/19 - 09:54 am
Triumvira
TAC01-CD19
immuno-oncology
Immunotherapy Focused NextCure Updates Its Filing for $93 Million IPO
CP Wire
Mon, 04/29/19 - 10:04 am
NextCure
IPOs
immuno-oncology
Immunotherapy Focused NextCure Updates Its Filing for $93 Million IPO
Mon, 04/29/19 - 10:04 am
NextCure
NC318
immuno-oncology
Daiichi picks immuno-oncology bispecific, triggering payout to Zymeworks
Fierce Biotech
Thu, 04/25/19 - 11:45 am
Daiichi Sankyo
immuno-oncology
Zymeworks
bispecific antibodies
Biomica Initiates Microbiome Based Immuno-Oncology Studies
CP Wire
Wed, 04/17/19 - 09:48 am
Biomica
microbiome
immuno-oncology
BMC-121
BMC-127
Biomica Initiates Microbiome Based Immuno-Oncology Studies
Wed, 04/17/19 - 09:44 am
Biomica
microbiome
immuno-oncology
BMC-121
BMC-127
What causes immuno-oncology drug resistance? 2 research teams uncover clues
Fierce Biotech
Fri, 04/5/19 - 10:32 am
R&D
immuno-oncology
checkpoint inhibitors
Enterome to Present Data on its Microbiome-Derived Molecular Mimicry Approach to Cancer Immunotherapy
CP Wire
Thu, 03/28/19 - 12:04 pm
Enterome
immuno-oncology
glioblastoma multiforme
molecular mimicry
Enterome to Present Data on its Microbiome-Derived Molecular Mimicry Approach to Cancer Immunotherapy
Thu, 03/28/19 - 11:55 am
Enterome
immuno-oncology
glioblastoma multiforme
Roche-backed Arch Oncology gets off $50M round for anti-CD47 cancer work
Fierce Biotech
Mon, 03/25/19 - 11:55 am
Arch Oncology
Roche
immuno-oncology
Analysts: Keytruda has a blockbuster market not factored into Merck’s forecasts—China
Fierce Pharma
Fri, 03/15/19 - 12:20 pm
Merck
Keytruda
immuno-oncology
China
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »